Sort

Search

01/01/2025 Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024)
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024). Antibiotics-Basel. 2025; 14(1)DOI:10.3390/antibiotics14010004. PMID:39858394. IF:4.600(Q1/2D).
01/01/2025 EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Del Galdo, F, Lescoat, A, Conaghan, PG, Bertoldo, E, Colic, J, Santiago, T, Suliman, YA, Matucci-Cerinic, M, Gabrielli, A, Distler, O, Hoffmann-Vold, AM, Castellví, I, Balbir-Gurman, A, Vonk, M, Ananyeva, L, Rednic, S, Tarasova, A, Ostojic, P, Boyadzhieva, V, El Aoufy, K, Farrington, S, Galetti, I, Denton, CP, Kowal-Bielecka, O, Mueller-Ladner, U, Allanore, Y. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84(1)DOI:10.1136/ard-2024-226430. PMID:39874231. IF:20.600(Q1/1D).
01/01/2025 Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments
Juárez, FR, de Vicuña, RG, Vicente, E, Almaraz, ER, Rivas, NL, González, MF, Marqués, AO, Nack, A, García, JN, Alvarado, PM, Itzazelaia, EU, Lorenzo, NA, de la Fuente, JLM, Ramos, C, Aransay, VP, Alonso, RB, Villanueva, FB, Vidal, MPM, Martín, JMG, Rúa-Figueroa, I. Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments. Reumatologia Clinica. 2025; 21(1)DOI:10.1016/j.reuma.2024.10.007. PMID:. IF:(Q/D).
01/01/2025 Gout therapy updated
McCarty, KL, Gaffo, AL, Diaz-Torne, C. Gout therapy updated. Therapeutic Advances in Musculoskeletal Disease. 2025; 17DOI:10.1177/1759720X251384584. PMID:41146690. IF:4.100(Q1/3D).
01/01/2025 Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62 (6) (2024), 987-994]
Domingo, C, Quirce, S, Dávila, I, Crespo-Lessman, A, Arismendi, E, De Diego, A, González-Barcala, FJ, de Llano, LP, Cea-Calvo, L, Sanchez-Jareño, M, López-Cotarelo, P, Puente-Maestu, L. Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62 (6) (2024), 987-994]. Respiratory Investigation. 2025; 63(1)DOI:10.1016/j.resinv.2024.12.004. PMID:39667093. IF:(Q/D).
01/01/2025 Minimally-invasive electrical impedance spectroscopy in lung tissue: present and future trends
Riu, PJ, Company-Se, G, Codern, AR, Castany, AF, Pajares, V, Rosell, J, Bragós, R, Nescolarde, L. Minimally-invasive electrical impedance spectroscopy in lung tissue: present and future trends. INTERNATIONAL CONFERENCE ON ELECTRICAL BIOIMPEDANCE, AND ELECTRICAL IMPEDANCE TOMOGRAPHY 2025, ICEBI EIT CNIBI 2025. 2025; 3014DOI:10.1088/1742-6596/3014/1/012004. PMID:. IF:(Q/D).